Alexander M. Andrianov

Ac. Kuprevich St, 5/2
MI 220141, Belarus

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Design, in silico Evaluation, and Determination of Antitumor Activity of Potential Inhibitors Against Protein Kinases: Application to BCR-ABL Tyrosine Kinase.

Design, in silico Evaluation, and Determination of Antitumor Activity of Potential Inhibitors Against Protein Kinases: Application to BCR-ABL Tyrosine Kinase.

Journal: Biochemistry. Biokhimiia

Published: July 09, 2024

Virtual screening and identification of promising therapeutic compounds against drug-resistant Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase I (KasA).

Virtual screening and identification of promising therapeutic compounds against drug-resistant Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase I (KasA).

Journal: Journal of biomolecular structure & dynamics

Published: December 13, 2023

Repurposing Navitoclax to block SARS-CoV-2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein.

Repurposing Navitoclax to block SARS-CoV-2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein.

Journal: Journal of medical virology

Published: May 25, 2023

AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease.

AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease.

Journal: International journal of molecular sciences

Published: March 14, 2023

In silico design and computational evaluation of novel 2-arylaminopyrimidine-based compounds as potential multi-targeted protein kinase inhibitors: application for the native and mutant (T315I) Bcr-Abl tyrosine kinase.

In silico design and computational evaluation of novel 2-arylaminopyrimidine-based compounds as potential multi-targeted protein kinase inhibitors: application for the native and mutant (T315I) Bcr-Abl tyrosine kinase.

Journal: Journal of biomolecular structure & dynamics

Published: April 26, 2022

Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodies.

Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodies.

Journal: Cell chemical biology

Published: November 27, 2021

Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors.

Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors.

Journal: Journal of biomolecular structure & dynamics

Published: April 15, 2021

Metabolomic profiling of three Araucaria species, and their possible potential role against COVID-19.

Metabolomic profiling of three Araucaria species, and their possible potential role against COVID-19.

Journal: Journal of biomolecular structure & dynamics

Published: February 18, 2021

Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.

Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.

Journal: Journal of biomolecular structure & dynamics

Published: July 15, 2020

In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.

In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.

Journal: Viruses

Published: July 10, 2019

Potential HIV-1 fusion inhibitors mimicking gp41-specific broadly neutralizing antibody 10E8: In silico discovery and prediction of antiviral potency.

Potential HIV-1 fusion inhibitors mimicking gp41-specific broadly neutralizing antibody 10E8: In silico discovery and prediction of antiviral potency.

Journal: Journal of bioinformatics and computational biology

Published: February 15, 2018

Computational identification of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120.

Computational identification of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120.

Journal: Journal of molecular modeling

Published: June 15, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026